Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $29.6 million.

  • Bioventus' Free Cash Flow rose 18896.8% to $29.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.5 million, marking a year-over-year increase of 8409.08%. This contributed to the annual value of $37.8 million for FY2024, which is 27226.87% up from last year.
  • Bioventus' Free Cash Flow amounted to $29.6 million in Q3 2025, which was up 18896.8% from $25.3 million recorded in Q2 2025.
  • In the past 5 years, Bioventus' Free Cash Flow registered a high of $29.6 million during Q3 2025, and its lowest value of -$24.0 million during Q2 2022.
  • Moreover, its 5-year median value for Free Cash Flow was $8.7 million (2021), whereas its average is $4.1 million.
  • As far as peak fluctuations go, Bioventus' Free Cash Flow skyrocketed by 93388.34% in 2023, and later plummeted by 67288.44% in 2024.
  • Bioventus' Free Cash Flow (Quarter) stood at $4.2 million in 2021, then skyrocketed by 149.82% to $10.4 million in 2022, then dropped by 3.84% to $10.0 million in 2023, then soared by 87.39% to $18.7 million in 2024, then surged by 58.02% to $29.6 million in 2025.
  • Its Free Cash Flow stands at $29.6 million for Q3 2025, versus $25.3 million for Q2 2025 and -$20.2 million for Q1 2025.